ESR2 and neoplasm: This underscores the importance of determining the ability of ERβ to signal from the tumor microenvironment to regulate tumor development and metastasis and the capacity of ligands to enhance ERβ signaling in these cells and achieve favorable clinical outcomes by potentiating the anti-tumor activity of the host immune system.